318 related articles for article (PubMed ID: 24219354)
1. Effect of antimicrobial agents incorporated into resilient denture relines on the Candida albicans biofilm.
Bueno MG; Urban VM; Barbério GS; da Silva WJ; Porto VC; Pinto L; Neppelenbroek KH
Oral Dis; 2015 Jan; 21(1):57-65. PubMed ID: 24219354
[TBL] [Abstract][Full Text] [Related]
2. Effect of Incorporation of Antifungal Agents on the Ultimate Tensile Strength of Temporary Soft Denture Liners.
Neppelenbroek KH; Lima JFM; Hotta J; Galitesi LL; Almeida ALPF; Urban VM
J Prosthodont; 2018 Feb; 27(2):177-181. PubMed ID: 29135059
[TBL] [Abstract][Full Text] [Related]
3. Surface Properties of Temporary Soft Liners Modified by Minimum Inhibitory Concentrations of Antifungals.
Bueno MG; Sousa EJB; Hotta J; Porto VC; Urban VM; Neppelenbroek KH
Braz Dent J; 2017; 28(2):158-164. PubMed ID: 28492744
[TBL] [Abstract][Full Text] [Related]
4. Surface morphology and in vitro leachability of soft liners modified by the incorporation of antifungals for denture stomatitis treatment.
SÁnchez-Aliaga A; Farago PV; MichÉl MD; Sugio CYC; Neppelenbroek KH; Urban VM
J Appl Oral Sci; 2021 Feb; 28():e20200639. PubMed ID: 33656098
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Candida albicans biofilm formation on denture material.
Redding S; Bhatt B; Rawls HR; Siegel G; Scott K; Lopez-Ribot J
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):669-72. PubMed ID: 19426921
[TBL] [Abstract][Full Text] [Related]
6. Porosity of temporary denture soft liners containing antifungal agents.
Lima JF; Maciel JG; Hotta J; Vizoto AC; Honório HM; Urban VM; Neppelenbroek KH
J Appl Oral Sci; 2016; 24(5):453-461. PubMed ID: 27812615
[TBL] [Abstract][Full Text] [Related]
7. Effect of the addition of antimicrobial agents on Shore A hardness and roughness of soft lining materials.
Urban VM; Lima TF; Bueno MG; Giannini M; Arioli Filho JN; de Almeida AL; Neppelenbroek KH
J Prosthodont; 2015 Apr; 24(3):207-14. PubMed ID: 25082183
[TBL] [Abstract][Full Text] [Related]
8. In vivo biocompatibility of an interim denture resilient liner containing antifungal drugs.
Hotta J; Garlet GP; Cestari TM; Lima JFM; Porto VC; Urban VM; Neppelenbroek KH
J Prosthet Dent; 2019 Jan; 121(1):135-142. PubMed ID: 30646999
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.
Lamfon H; Porter SR; McCullough M; Pratten J
J Antimicrob Chemother; 2004 Feb; 53(2):383-5. PubMed ID: 14729749
[TBL] [Abstract][Full Text] [Related]
10. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
[TBL] [Abstract][Full Text] [Related]
11. Effect of denture liners surface modification with
Garcia CR; Ueda TY; da Silva RA; Cano IP; Saldanha LL; Dokkedal AL; Porto VC; Urban VM; Neppelenbroek KH
Ther Deliv; 2022 Mar; 13(3):157-166. PubMed ID: 35195016
[No Abstract] [Full Text] [Related]
12. Effect of incorporating antifungals on the water sorption and solubility of interim resilient liners for denture base relining.
Lima JF; Maciel JG; Arrais CA; Porto VC; Urban VM; Neppelenbroek KH
J Prosthet Dent; 2016 May; 115(5):611-6. PubMed ID: 26794705
[TBL] [Abstract][Full Text] [Related]
13. Stability and efficacy of combined nystatin and chlorhexidine against suspensions and biofilms of Candida albicans.
Scheibler E; da Silva RM; Leite CE; Campos MM; Figueiredo MA; Salum FG; Cherubini K
Arch Oral Biol; 2018 May; 89():70-76. PubMed ID: 29477025
[TBL] [Abstract][Full Text] [Related]
14. Resilient liner modified by antimicrobials for denture stomatitis treatment: A randomized controlled trial.
Procópio ALF; Lara VS; Porto VC; Soares S; Fernandes MH; Urban VM; Neppelenbroek KH
J Dent; 2022 Nov; 126():104297. PubMed ID: 36122605
[TBL] [Abstract][Full Text] [Related]
15. In vitro antifungal activity of two tissue conditioners combined with nystatin, miconazole and fluconazole against Candida albicans.
Chopde N; Pharande A; Khade MN; Khadtare YR; Shah SS; Apratim A
J Contemp Dent Pract; 2012 Sep; 13(5):695-8. PubMed ID: 23250177
[TBL] [Abstract][Full Text] [Related]
16. Candida albicans biofilm formation on soft denture liners and efficacy of cleaning protocols.
Hahnel S; Rosentritt M; Bürgers R; Handel G; Lang R
Gerodontology; 2012 Jun; 29(2):e383-91. PubMed ID: 21585518
[TBL] [Abstract][Full Text] [Related]
17. Exopolysaccharide matrix of developed Candida albicans biofilms after exposure to antifungal agents.
da Silva WJ; Gonçalves LM; Seneviratne J; Parahitiyawa N; Samaranayake LP; Del Bel Cury AA
Braz Dent J; 2012; 23(6):716-22. PubMed ID: 23338267
[TBL] [Abstract][Full Text] [Related]
18. Intraoral Device for Optimal Antifungal Delivery in a Rat Model.
Hotta J; Cral WG; Sakima VT; Lara VS; Urban VM; Neppelenbroek KH
Curr Drug Deliv; 2017; 14(5):658-667. PubMed ID: 27739378
[TBL] [Abstract][Full Text] [Related]
19. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
20. Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms.
Monteiro DR; Silva S; Negri M; Gorup LF; de Camargo ER; Oliveira R; Barbosa DB; Henriques M
Mycoses; 2013 Nov; 56(6):672-80. PubMed ID: 23773119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
